Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WCN 2021 | Publishing scientific articles in the COVID-19 era

Didier Leys, MD, PhD, FAAN, FEAN, University of Lille, Lille, France, talks on publishing COVID-19-related studies in the European Journal of Neurology. Dr Leys explains that during the pandemic, the journal received a large number of case reports and case series of neurological disorders in patients with COVID-19 and in vaccinated patients. Since such papers do not prove an association between disease or vaccination and neurological events, it is more meaningful to conduct case-control studies. This is particularly important in the context of COVID-19 vaccines, where people might use case reports as an argument against vaccination. Therefore, the journal decided to publish only well-conducted case-control studies. Currently, the journal is focusing on the long-term effects of COVID-19. It is also important to address the management of patients with neurodegenerative diseases during the pandemic. Finally, Dr Leys mentions recently published studies in the European Journal of Neurology. This interview took place during the XXV World Congress of Neurology.